Tyson Foods, Inc. vs Zoetis Inc — how do they compare? Tyson Foods, Inc. trades at $53.43 (market cap $18.41B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is the larger of the two by market cap, and Tyson Foods, Inc. pays the higher dividend (3.9%). Which is the better fit depends on your goals — on Pluang, investors hold Tyson Foods, Inc. for 76 Days and Zoetis Inc for 70 Days on average.
| TSN | ZTS | |
|---|---|---|
Market Cap | $18.41B | $30.20B |
Volume | 3,757,599 | 6,175,327 |
Sector | Consumer Staples | Health |
52-Week High | $68.75 | $147.53 |
52-Week Low | $50.47 | $69.09 |
Typical Hold Time | 76 Days | 70 Days |
Enterprise Value | $25.68B | $37.76B |
Dividend Yield | 3.9% | 2.9% |
Signals from Pluang's Aura AI — not financial advice
Tyson Foods (TSN) trades at $53.43, up 3.35% with mixed technical signals showing bullish overall but bearish moving averages. The company reported Q2 2026 EPS of $0.99, beating expectations, but faces challenges with thin 1.03% net margins and ongoing beef segment losses. Recent news highlights securities investigations and reduced 2026 revenue guidance, creating investor uncertainty despite institutional buying activity.
The stock presents a cautious opportunity with analyst consensus target of $65.40 (22% upside) but faces significant headwinds from margin pressure and legal scrutiny. Key risks include beef segment profitability, potential securities violations, and volatile cash flow patterns. Upside depends on operational improvements and resolution of ongoing investigations.
Zoetis (ZTS) trades at $74.77, up 4.5% with strong profitability metrics including 71.67% gross margins and 27.69% net income margin. The stock shows mixed technical signals with bullish oscillators but bearish moving averages, trading near resistance at $75. Recent earnings show beats in Q4 2025 and Q2 2026 but a miss in Q1 2026, with Q3 2026 results pending. The company maintains robust cash flow generation despite competitive pressures in the U.S. companion animal market.
Zoetis presents a compelling value opportunity with a P/E of 11.92 below industry averages, though near-term headwinds from pet care weakness and competition persist. Analyst consensus targets $87.33 with no sell ratings, suggesting 17% upside potential. Key risks include ongoing margin pressure and market share challenges, but strong international growth and dividend sustainability support long-term bullish thesis.
Trailing returns across standard periods
Latest headlines on both assets
Tyson Foods is the largest U.S. producer of processed chicken and beef. It's also a large producer of processed pork and protein-based products under the brands Jimmy Dean, Hillshire Farm, Ball Park, Sara Lee, Aidells, State Fair, and Raised & Rooted, to name a few. Tyson sells 81% of its products through various U.S. channels, including retailers (47% in fiscal 2021), food service (32%), and other packaged food and industrial companies (10%). In addition, 11% of the company's revenue comes from exports to Canada, Mexico, Brazil, Europe, China, and Japan.
Read more on TSN →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →